Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arzoxifene hydrochloride in recurrent or advanced endometrial cancer
NCT00003669Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of arzoxifene in endometrial cancer (EC), sponsored by Eli Lilly and Company. Started Nov 1998; status: completed.
02
Drugs
arzoxifene
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT00003669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003669.